A terapia fotodinâmica (TFD) é uma modalidade clínica para tratar uma variedade de neoplasias, doenças de pele e representa um promissor tratamento estético. O presente trabalho avaliou os aspectos histopatológicos e moleculares do tratamento pela TFD mediada por azul de metileno (TFD-AM) no modelo experimental in vivo do Carcinoma Espinocelular Cutâneo (CEC) e na pele sadia de camundongos Swiss. O protocolo da TFD foi de uma única sessão, com aplicação da solução de AM a 1% seguido por irradiação com laser diodo na dose total de 24 J/cm2 nos tecidos tumorais e sadios. Os animais foram sacrificados em dois períodos, 24 horas e 15 dias após TFD. Alterações morfológicas foram pouco marcantes nos tecidos tumorais tratados, entretanto, foram mais pronunciadas nos tecidos sadios. Podemos concluir que os efeitos de uma única sessão da TFD mediada pelo AM na dose aplicada não conferiu melhora no tratamento do CEC. Estes resultados motivam novos estudos com ajustes no protocolo para melhorar a eficácia desta terapia. / Photodynamic therapy (PDT) is a clinical method for treating a variety of tumors, skin disorders and represents a promising cosmetic treatment. This study evaluated the histopathological and molecular aspects of the treatment by PDT mediated by methylene blue (PDT-MB) in vivo experimental model of cutaneous squamous cell carcinoma (SCC) and in healthy skin of swiss mice. The PDT protocol was a single session with the application of MB 1% solution followed by irradiation with diode laser at a total dose of 24 J/cm2 in tumor and healthy tissue. The animals were sacrificed at two periods, 24 hours and 15 days after PDT. Morphological changes were less marked in the tumor tissues treated, however, were more pronounced in healthy tissues treated. We can conclude that the effects of a single session of PDT mediated by MB in applied dose conferred no improvement in the treatment of SCC. These results motivate further studies with adjustments in the protocol to improve the effectiveness of this therapy.

O câncer de mama é a neoplasia mais comum na população feminina, representando até um terço dos novos diagnósticos de neoplasia nessa população em algumas regiões do mundo. A prevenção primária ou secundária constitui a pedra fundamental no controle do câncer de mama; depende da identificação dos determinantes da doença, em termos de iniciação e promoção. Aproximadamente, 48.930 novos casos de câncer de mama são detectados anualmente no Brasil, tornando-se um sério problema de saúde pública. O objetivo primário deste estudo foi avaliar a ação e diferenças de dois SERMs, tamoxifeno (TAM) e raloxifeno (RAL), na quimioprevenção de tumores mamários quimicamente induzidos em ratas. Foram estudados três grupos homogêneos (DMBA ou 7,12-Dimetilbenzantraceno, TAM e RAL) compostos de 20 ratas adultas da raça Sprague-Dawley com tumores induzidos quimicamente pelo carcinógeno DMBA. As ratas, com 40 a 50 dias de vida, receberam a substância em dose única, por gavagem. Nos grupos TAM e RAL, os animais receberam os SERMs, diariamente, por via oral, 10 dias antes e por mais 80 dias após a indução química com o DMBA. A ação destes SERMs na quimioprevenção de tumores mamários, como também as características morfológicas e histopatológicas dos tumores induzidos, a porcentagem de receptores de estrogênio e a atividade proliferativa da célula tumoral pelo Ki67 foram analisadas. A expressão angiogênica em cada grupo e suas diferenças foram avaliadas com o método qRT-PCR. Após a análise estatística dos resultados observou-se, em relação aos três grupos, que não houve diferenças significantes quanto ao peso, tipo histológico do tumor formado, porcentagem dos receptores de estrogênio e a média do tamanho tumoral. Houve diferenças estatísticas quanto a: 1) número de ratas que desenvolveram tumores (DMBA 100%, tamoxifeno 35% e raloxifeno 15%) ; 2) indução do aparecimento do tumor (DMBA = 32 dias, TAM=46 dias e RAL=57 dias); 3) média, por rata, de tumores formados em cada grupo (DMBA=4,5 tumores, TAM=1,33 tumores e RAL=1,28 tumores); 4) porcentagem de células Ki-67 positivas nos tumores: DMBA 85% dos casos Ki67= 75% a 80%, 15% dos casos Ki67=50%; TAM 43% dos casos Ki57=50% e 57% dos casos Ki67=75% ,e RAL 100% dos casos Ki67=50%; 5) grau histológico tumoral: DMBA 100% grau 3; TAM 71% grau 2 e 29% grau 3 , RAL 100% grau 2; 6) a avaliação da expressão de fatores angiogênicos: nos grupos TAM vs DMBA apresentou maior expressão nos genes Angpt1, Angpt2, Hqf, Hif1a, Itgab3, Lep, Mapk14,Mmp19 predicted, Nrp1, Pgf, Plau, Serpinf1, Tgfb1, Tgfb2, Tek, Timp3, TNF, Vegfa e Vegfc. No grupo RAL vs DMBA, apresentaram maior expressão os genes Hif1a, Itgab3 , Pgf, Plau, Tek e Vegfc. Este grupo mostrou, ainda, menor expressão dos genes Fgf6 e Pecam. Neste modelo experimental, houve maior eficácia do raloxifeno em relação ao tamoxifeno na quimioprevenção mamária; possivelmente, esta maior proteção esteja relacionada com os diferentes fatores angiogênicos expressos nos dois grupos. / Breast cancer is the most common neoplastic disease in the female population, accounting for up to one third of new cancer cases in women in some regions of the world. Prevention, either primary or secondary, is essential for breast cancer control, which depends on identification of the determining factor of the disease, both for initiation and promotion. About 48,930 new cases of breast cancer are detected annually in Brazil, creating a serious Public Health problem. The primary objective of the present study was to determine the action of two SERMs (tamoxifen and raloxifene) as chemopreventive agents and to check the differences between them. The secondary objectives were to evaluate morphological and histological aspects, the percentage of estrogen receptor and proliferative mammary activity (Ki67), and expression of 84 genes involved in modulating the biological process of angiogenesis by qRT-PCR array. Young female Sprague-Dawley rats had chemically-induced tumors by DMBA (7,12Dimethylbenzanthracene) administered by gavage between the ages of 40 to 50 days old. They were divided into three groups: DMBA, TAM and RAL; the two latter groups received SERMs 10 days before DMBA and for 80 days after it. Data analyses showed: 1) the number of rats that developed tumors in each group (DMBA = 20 rats - 100%; TAM = 7 rats - 35%; RAL = 3 rats -15%); 2) induction of tumor onset (DMBA = 32 days, TAM = 46 days, RAL = 57 days); 3) number of tumors formed in each group by individual rat (DMBA = 4.5; TAM = 1.33, and RAL = 1.28); 4) the percentage of Ki67 positive cells in tumors (DMBA = 50 to 80%, TAM = 50 to 75%, and RAL = 50%); 5) histological grade of mammary tumor (DMBA = 100% grade 3, TAM = 71% grade 2 and 29% grade 3, and RAL = 100% grade 2); 6) assessment of expression of angiogenic factors. TAM group compared to DMBA group showed greater expression of the following genes: Angpt2, Hqf, Hif1a, Itgab3, Lep, Mapk14, mmp19 predicted, Nrp1, Pgf, Plau, Serpinf1, Tgfb1, Tgfb2, Tek, Timp3, TNF, Vegfa and Vegfc. RAL group compared to DMBA group showed greater expression of genes Hif1a, Itgab3, Pgf, Plau, Tek and Vegfc; in addition, in this group, genes Fgf6 and Pecam had less expression. In conclusion, in this experimental model, the raloxifene group proved to be more efficient than the tamoxifen group in mammary chemoprevention. The results can be possibly associated with different expressions of angiogenic factors in both groups

O câncer de mama é a neoplasia mais comum na população feminina, representando até um terço dos novos diagnósticos de neoplasia nessa população em algumas regiões do mundo. A prevenção primária ou secundária constitui a pedra fundamental no controle do câncer de mama; depende da identificação dos determinantes da doença, em termos de iniciação e promoção. Aproximadamente, 48.930 novos casos de câncer de mama são detectados anualmente no Brasil, tornando-se um sério problema de saúde pública. O objetivo primário deste estudo foi avaliar a ação e diferenças de dois SERMs, tamoxifeno (TAM) e raloxifeno (RAL), na quimioprevenção de tumores mamários quimicamente induzidos em ratas. Foram estudados três grupos homogêneos (DMBA ou 7,12-Dimetilbenzantraceno, TAM e RAL) compostos de 20 ratas adultas da raça Sprague-Dawley com tumores induzidos quimicamente pelo carcinógeno DMBA. As ratas, com 40 a 50 dias de vida, receberam a substância em dose única, por gavagem. Nos grupos TAM e RAL, os animais receberam os SERMs, diariamente, por via oral, 10 dias antes e por mais 80 dias após a indução química com o DMBA. A ação destes SERMs na quimioprevenção de tumores mamários, como também as características morfológicas e histopatológicas dos tumores induzidos, a porcentagem de receptores de estrogênio e a atividade proliferativa da célula tumoral pelo Ki67 foram analisadas. A expressão angiogênica em cada grupo e suas diferenças foram avaliadas com o método qRT-PCR. Após a análise estatística dos resultados observou-se, em relação aos três grupos, que não houve diferenças significantes quanto ao peso, tipo histológico do tumor formado, porcentagem dos receptores de estrogênio e a média do tamanho tumoral. Houve diferenças estatísticas quanto a: 1) número de ratas que desenvolveram tumores (DMBA 100%, tamoxifeno 35% e raloxifeno 15%) ; 2) indução do aparecimento do tumor (DMBA = 32 dias, TAM=46 dias e RAL=57 dias); 3) média, por rata, de tumores formados em cada grupo (DMBA=4,5 tumores, TAM=1,33 tumores e RAL=1,28 tumores); 4) porcentagem de células Ki-67 positivas nos tumores: DMBA 85% dos casos Ki67= 75% a 80%, 15% dos casos Ki67=50%; TAM 43% dos casos Ki57=50% e 57% dos casos Ki67=75% ,e RAL 100% dos casos Ki67=50%; 5) grau histológico tumoral: DMBA 100% grau 3; TAM 71% grau 2 e 29% grau 3 , RAL 100% grau 2; 6) a avaliação da expressão de fatores angiogênicos: nos grupos TAM vs DMBA apresentou maior expressão nos genes Angpt1, Angpt2, Hqf, Hif1a, Itgab3, Lep, Mapk14,Mmp19 predicted, Nrp1, Pgf, Plau, Serpinf1, Tgfb1, Tgfb2, Tek, Timp3, TNF, Vegfa e Vegfc. No grupo RAL vs DMBA, apresentaram maior expressão os genes Hif1a, Itgab3 , Pgf, Plau, Tek e Vegfc. Este grupo mostrou, ainda, menor expressão dos genes Fgf6 e Pecam. Neste modelo experimental, houve maior eficácia do raloxifeno em relação ao tamoxifeno na quimioprevenção mamária; possivelmente, esta maior proteção esteja relacionada com os diferentes fatores angiogênicos expressos nos dois grupos. / Breast cancer is the most common neoplastic disease in the female population, accounting for up to one third of new cancer cases in women in some regions of the world. Prevention, either primary or secondary, is essential for breast cancer control, which depends on identification of the determining factor of the disease, both for initiation and promotion. About 48,930 new cases of breast cancer are detected annually in Brazil, creating a serious Public Health problem. The primary objective of the present study was to determine the action of two SERMs (tamoxifen and raloxifene) as chemopreventive agents and to check the differences between them. The secondary objectives were to evaluate morphological and histological aspects, the percentage of estrogen receptor and proliferative mammary activity (Ki67), and expression of 84 genes involved in modulating the biological process of angiogenesis by qRT-PCR array. Young female Sprague-Dawley rats had chemically-induced tumors by DMBA (7,12Dimethylbenzanthracene) administered by gavage between the ages of 40 to 50 days old. They were divided into three groups: DMBA, TAM and RAL; the two latter groups received SERMs 10 days before DMBA and for 80 days after it. Data analyses showed: 1) the number of rats that developed tumors in each group (DMBA = 20 rats - 100%; TAM = 7 rats - 35%; RAL = 3 rats -15%); 2) induction of tumor onset (DMBA = 32 days, TAM = 46 days, RAL = 57 days); 3) number of tumors formed in each group by individual rat (DMBA = 4.5; TAM = 1.33, and RAL = 1.28); 4) the percentage of Ki67 positive cells in tumors (DMBA = 50 to 80%, TAM = 50 to 75%, and RAL = 50%); 5) histological grade of mammary tumor (DMBA = 100% grade 3, TAM = 71% grade 2 and 29% grade 3, and RAL = 100% grade 2); 6) assessment of expression of angiogenic factors. TAM group compared to DMBA group showed greater expression of the following genes: Angpt2, Hqf, Hif1a, Itgab3, Lep, Mapk14, mmp19 predicted, Nrp1, Pgf, Plau, Serpinf1, Tgfb1, Tgfb2, Tek, Timp3, TNF, Vegfa and Vegfc. RAL group compared to DMBA group showed greater expression of genes Hif1a, Itgab3, Pgf, Plau, Tek and Vegfc; in addition, in this group, genes Fgf6 and Pecam had less expression. In conclusion, in this experimental model, the raloxifene group proved to be more efficient than the tamoxifen group in mammary chemoprevention. The results can be possibly associated with different expressions of angiogenic factors in both groups

No description available.

A terapia fotodinâmica (TFD) é uma modalidade clínica para tratar uma variedade de neoplasias, doenças de pele e representa um promissor tratamento estético. O presente trabalho avaliou os aspectos histopatológicos e moleculares do tratamento pela TFD mediada por azul de metileno (TFD-AM) no modelo experimental in vivo do Carcinoma Espinocelular Cutâneo (CEC) e na pele sadia de camundongos Swiss. O protocolo da TFD foi de uma única sessão, com aplicação da solução de AM a 1% seguido por irradiação com laser diodo na dose total de 24 J/cm2 nos tecidos tumorais e sadios. Os animais foram sacrificados em dois períodos, 24 horas e 15 dias após TFD. Alterações morfológicas foram pouco marcantes nos tecidos tumorais tratados, entretanto, foram mais pronunciadas nos tecidos sadios. Podemos concluir que os efeitos de uma única sessão da TFD mediada pelo AM na dose aplicada não conferiu melhora no tratamento do CEC. Estes resultados motivam novos estudos com ajustes no protocolo para melhorar a eficácia desta terapia. / Photodynamic therapy (PDT) is a clinical method for treating a variety of tumors, skin disorders and represents a promising cosmetic treatment. This study evaluated the histopathological and molecular aspects of the treatment by PDT mediated by methylene blue (PDT-MB) in vivo experimental model of cutaneous squamous cell carcinoma (SCC) and in healthy skin of swiss mice. The PDT protocol was a single session with the application of MB 1% solution followed by irradiation with diode laser at a total dose of 24 J/cm2 in tumor and healthy tissue. The animals were sacrificed at two periods, 24 hours and 15 days after PDT. Morphological changes were less marked in the tumor tissues treated, however, were more pronounced in healthy tissues treated. We can conclude that the effects of a single session of PDT mediated by MB in applied dose conferred no improvement in the treatment of SCC. These results motivate further studies with adjustments in the protocol to improve the effectiveness of this therapy.

Da vorliegende Studien unserer Arbeitsgruppe auf eine Beteiligung von Connexinen an der oralen Plattenepithelkarzinogenese hindeuten, war es Ziel dieser Arbeit in-vivo am Hamstermodell die Expression der Connexine 26, 43 und 45 im Verlauf der Karzinogenese zu untersuchen. Die durch 9,10-Dimethyl-1,2-Benzanthrazen (DMBA) induzierten Karzinome wurden makroskopisch, histologisch, sowie auf ihren Inflammationsgrad hin untersucht, um die Effektivität des Tiermodells zu prüfen. Weiterhin erfolgte sie Genexpressionsanalyse mittels RNA-Isolation, PCR-Analyse und statistischer Auswertung. Es konnte insgesamt gezeigt werden, dass die Applikation von DMBA in Abhängigkeit von Behandlungsdauer makroskopisch, histologisch und inflammatorisch einen deutlichen karzinogenen Effekt hatte und, dass das histopathologische Grading signifikant mit der Länge der Behandlungsdauer korrelierte. Im Rahmen der Genexpressionsanalyse konnte im Verlauf der DMBA-Behandlung für Connexin 26 und 45 eine signifikante Überexpression beschrieben werden. Connexin 43 zeigte sich als nicht differentiell exprimiert. Ein Zusammenhang zwischen histologischem Grading und Genexpression war nicht nachvollziehbar.

<p>I developed a precision-cut adrenal slice culture procedure to investigate cytochrome P450 (CYP) catalysed irreversible binding and adrenocorticolytic effects in human, rodent, and fish adrenal tissue, <i>ex vivo</i>. Autoradiography and radioluminography of exposed tissue slices showed that the potent adrenal toxicant 3-methylsulphonyl-2,2´-bis(4-chlorophenyl)-1,1´-dichloroethene (MeSO₂-DDE) causes a selective metabolite binding in <i>zona fasciculata</i> (<i>ZF</i>), which is diminished by the CYP11B1 inhibitor metyrapone. MeSO₂-DDE also reduces corticosterone secretion, increases 11-deoxycorticosterone secretion and causes mitochondrial degeneration in <i>ZF</i> cells in cultured mouse adrenal slices. ACTH treatment of mice induces CYP11B1 and increases irreversible MeSO₂-DDE binding and toxicity in <i>ZF</i> cells. Metyrapone-sensitive binding of MeSO₂-DDE is also observed in human <i>zona fasciculata/reticularis</i> (<i>ZF/ZR</i>) and 11-deoxycorti- sol/corticosterone secretion increases in MeSO₂-DDE-exposed cultured human adrenal slices. The adrenocorticolytic drug 2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichlorethane (o,p´- DDD, Mitotane^®) is also bound in <i>ZF/ZR </i>but does not to impair hormone secretion in human adrenal slices at equimolar concentration. A targeted, presumably CYP1B1-catalysed irreversible binding of the adrenocorticolytic carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) in <i>ZF/ZR </i>occurs in rat adrenal slices, whereas presumably CYP1A1-catalysed irreversible binding in endothelial cells is observed in CYP1-induced rats and mice. The rat-specific adrenocorticolytic activity of DMBA may rely on two independent pathological processes resulting in cell death and haemorrhage in the adrenal cortex. In Atlantic cod, selective binding of o,p´-DDD is observed in interrenal cells in cultured anterior kidney slices.</p><p>In conclusion, precision-cut adrenal slice culture is a simple <i>ex vivo</i> test system with which to investigate CYP-catalysed metabolite binding, alteredsteroid hormone secretion and target cell ultrastructure in human, experimental and wild animal tissue. The results imply that organisms under stress could be at increased risk of MeSO₂-DDE induced adrenal toxicity. MeSO₂-DDE is an expected human adrenal toxicant, which should be evaluated as a possible alternative in the therapy of adrenocortical hypersecretion and tumour growth.</p>

I developed a precision-cut adrenal slice culture procedure to investigate cytochrome P450 (CYP) catalysed irreversible binding and adrenocorticolytic effects in human, rodent, and fish adrenal tissue, ex vivo. Autoradiography and radioluminography of exposed tissue slices showed that the potent adrenal toxicant 3-methylsulphonyl-2,2´-bis(4-chlorophenyl)-1,1´-dichloroethene (MeSO2-DDE) causes a selective metabolite binding in zona fasciculata (ZF), which is diminished by the CYP11B1 inhibitor metyrapone. MeSO2-DDE also reduces corticosterone secretion, increases 11-deoxycorticosterone secretion and causes mitochondrial degeneration in ZF cells in cultured mouse adrenal slices. ACTH treatment of mice induces CYP11B1 and increases irreversible MeSO2-DDE binding and toxicity in ZF cells. Metyrapone-sensitive binding of MeSO2-DDE is also observed in human zona fasciculata/reticularis (ZF/ZR) and 11-deoxycorti- sol/corticosterone secretion increases in MeSO2-DDE-exposed cultured human adrenal slices. The adrenocorticolytic drug 2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichlorethane (o,p´- DDD, Mitotane®) is also bound in ZF/ZR but does not to impair hormone secretion in human adrenal slices at equimolar concentration. A targeted, presumably CYP1B1-catalysed irreversible binding of the adrenocorticolytic carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) in ZF/ZR occurs in rat adrenal slices, whereas presumably CYP1A1-catalysed irreversible binding in endothelial cells is observed in CYP1-induced rats and mice. The rat-specific adrenocorticolytic activity of DMBA may rely on two independent pathological processes resulting in cell death and haemorrhage in the adrenal cortex. In Atlantic cod, selective binding of o,p´-DDD is observed in interrenal cells in cultured anterior kidney slices. In conclusion, precision-cut adrenal slice culture is a simple ex vivo test system with which to investigate CYP-catalysed metabolite binding, alteredsteroid hormone secretion and target cell ultrastructure in human, experimental and wild animal tissue. The results imply that organisms under stress could be at increased risk of MeSO2-DDE induced adrenal toxicity. MeSO2-DDE is an expected human adrenal toxicant, which should be evaluated as a possible alternative in the therapy of adrenocortical hypersecretion and tumour growth.

Submitted by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2015-01-23T16:14:44Z No. of bitstreams: 5 lopes.pdf: 4584389 bytes, checksum: 490508b2570ae9d7329524ffc42068ef (MD5) license_url: 52 bytes, checksum: 3d480ae6c91e310daba2020f8787d6f9 (MD5) license_text: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) license.txt: 2109 bytes, checksum: aa477231e840f304454a16eb85a9235f (MD5) / Approved for entry into archive by Rodrigo Martins Cruz (rodrigo.cruz@ufvjm.edu.br) on 2015-02-10T10:36:20Z (GMT) No. of bitstreams: 5 lopes.pdf: 4584389 bytes, checksum: 490508b2570ae9d7329524ffc42068ef (MD5) license_url: 52 bytes, checksum: 3d480ae6c91e310daba2020f8787d6f9 (MD5) license_text: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) license.txt: 2109 bytes, checksum: aa477231e840f304454a16eb85a9235f (MD5) / Made available in DSpace on 2015-02-10T10:36:20Z (GMT). No. of bitstreams: 5 lopes.pdf: 4584389 bytes, checksum: 490508b2570ae9d7329524ffc42068ef (MD5) license_url: 52 bytes, checksum: 3d480ae6c91e310daba2020f8787d6f9 (MD5) license_text: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) license_rdf: 23898 bytes, checksum: e363e809996cf46ada20da1accfcd9c7 (MD5) license.txt: 2109 bytes, checksum: aa477231e840f304454a16eb85a9235f (MD5) Previous issue date: 2013 / A presente disserta??o consiste em dois artigos cient?ficos, sendo um artigo original e outro de revis?o. Em um dos artigos, os autores fizeram uma revis?o da literatura sobre c?ncer e pr?polis, abordando a carcinog?nese experimental induzida quimicamente pelo 9,10-dimetil-1,2-benzantraceno (DMBA), a composi??o qu?mica da pr?polis e seus efeitos quimiopreventivos. O objetivo do artigo de pesquisa foi avaliar a rea??o tecidual da mucosa lingual de hamsters, submetida ? aplica??o di?ria e alternada de DMBA e extrato etan?lico de pr?polis (EEP) de uma apresenta??o comercial. Materiais e m?todos: 60 hamsters foram divididos em tr?s grupos, com dois per?odos experimentais, 13 e 20 semanas. A borda lateral da l?ngua foi submetida ? aplica??o t?pica, di?ria e alternada de DMBA 0,5 % e EEP 30 % (grupo EEP, n = 20), DMBA 0,5 % e extrato aquoso de pr?polis (EAP) (grupo EAP, n = 20), DMBA 0,5 % e soro fisiol?gico (grupo DMBA, n = 20). Realizou-se an?lise da ocorr?ncia dos tipos de altera??es cl?nicas e histol?gicas. Mensurou-se a ?rea e volume das altera??es cl?nicas, a ocorr?ncia das altera??es estruturais (AE) e citol?gicas (AC) do tecido epitelial escamoso com atipias e a ?rea histol?gica dos carcinomas de c?lulas escamosas (CCE). Para a an?lise estat?stica, aplicaram-se os testes ANOVA, qui-quadrado, Kruskal-Wallis e Mann-Whitney. Resultados: Para todas as vari?veis analisadas, n?o houve diferen?as significativas na compara??o entre os grupos nos dois tempos experimentais. Em 13 semanas ocorreu uma ?nica les?o de CCE no grupo EEP. Em 20 semanas, a maior ocorr?ncia de CCE tamb?m foi no grupo EEP. Conclus?o: o EEP, com teor alco?lico de 30 %, favoreceu a rea??o tecidual da inicia??o e da promo??o da carcinog?nese, por mecanismos ainda n?o elucidados. / ABSTRACT This dissertation consists of two papers, the first one is a review and the second is an original paper. In the first article, the authors reviewed the literature on cancer and propolis, addressing experimental carcinogenesis, chemically induced by 9,10-dimethyl-1,2-benzanthracene (DMBA), the chemical composition of propolis and its chemopreventive effects. The aim of the research paper was to evaluate the?tissue response?of tongue mucosa of hamsters, subjected to daily and alternating application of ethanolic extract of propolis (EEP) of a commercial presentation. Materials and methods: 60 hamsters were divided into three groups, and two experimental periods, 13 and 20 weeks. The lateral edge of the tongue underwent daily and alternate topical application of DMBA 0.5% and 30% EEP (EEP group, n = 20), DMBA and 0.5% aqueous extract of propolis (EAP) (EAP group; n = 20), and DMBA 0.5%?saline (DMBA?group, n =?20). The occurrence of types of clinical and histological changes was analysed. The area and volume of clinical changes, the occurrence of structural (AE) and cytological (CA) changes of squamous epithelial tissue with atypia and the histological area of squamous cell carcinoma (SCC) were measured. For statistical analysis, ANOVA, chi-square and Kruskal-Wallis and Mann-Whitney test were applied. Results: For all variables, there were no significant differences when comparing the groups in the two experimental periods. In 13 weeks, a single lesion of SCC in EEP group was observed. At 20 weeks, the highest occurrence of SCC was also in the group EEP. Conclusion: the EEP, with an alcohol content of 30% favored tissue reaction of initiation and promotion of carcinogenesis by mechanisms not yet elucidated.

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.